Prévisions du marché des organisations de vente sous contrat pharmaceutique en Amérique du Nord jusqu\'en 2030 – Analyse régionale – par services (services commerciaux et services non commerciaux), modules (modules syndiqués et modules dédiés), domaine thérapeutique (troubles cardiovasculaires, oncologie, troubles métaboliques, neurologie, maladies orthopédiques , maladies infectieuses et autres) et utilisateur final (sociétés biopharmaceutiques et sociétés pharmaceutiques)
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis
6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 North America
11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1.2 US
11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Canada
11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Mexico
11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 CMIC Holdings Co Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Axxelus Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 IQVIA Holdings Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Peak Pharma Solutions Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QFR Solutions LLC
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Promoveo Health LLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Syneos Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aenova Holding GmbH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pfizer Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sales Focus Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. North America - PEST Analysis
Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. Axxelus Inc
3. CMIC Holdings Co Ltd
4. IQVIA Holdings Inc
5. Peak Pharma Solutions Inc
6. Pfizer Inc
7. Promoveo Health LLC
8. QFR Solutions LLC
9. Sales Focus Inc
10. Syneos Health Inc